NL-OMON23627暂停不适用
SARS-CoV-2 presence in the cerebrospinal fluid of COVID-19 patients with acute respiratory failure: a pilot study.
Zuyderland Medical Centre0 个研究点目标入组 10 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •At least 18 years of age
- •-Requires mechanical ventilation
- •-Proven SARS-CoV-2 infection
- •-Lumbar puncture possible within 48 hours of ICU admission
- •-Informed consent provided by either patient or legal representative
排除标准
- •-Contraindication for lumbar puncture
- •-Proven or suspected cerebrospinal fluid leak or other blood-brain barrier defects
- •-Any condition known to alter cerebrospinal fluid biochemistry
- •-Known or suspected cause for respiratory failure, other than COVID-19
- •-Any disease known for decreasing pulmonary capacity or compliance
研究者
相似试验
撤回
不适用
SARS-CoV-2 presence in the cerebrospinal fluid of COVID-19 patients with acute respiratory failure: a pilot study.NL-OMON49509Zuyderland Medisch Centrum10
尚未招募
不适用
A study to identify SARS-CoV-2 in Red Blood Cells in infected patients.CTRI/2021/01/030630All India Institute of Medical Sciences
招募中
不适用
COVID-19 associated brainstem encephalitis - is SARS-CoV-2 a neurotropic agent?COVID-19U07.1COVID-19, virus identifiedDRKS00021439Klinik für Neurologie und Neurophysiologie Universitätsklinikum Freiburg70
进行中（未招募）
1 期
eurotropism and neuroinflammation in COVID-19 patients with deliriumdeliriumEUCTR2020-005827-35-FRniversity Hospital of Toulouse25
招募中
不适用
Investigation of COVID-19 associated neurological comorbiditiesneurological comorbidityCOVID-19U07.1COVID-19, virus identifiedDRKS00023312niversitätsklinikum Essen250